Basic HTML Version
Table of Contents
View Full Version
Page 14 - FLIPBOOK
P. 14
Ipilimumab + Nivolumab vs Sunitinib FAVORABLE RISK Albiges L, et al. ESMO Open. 2020
9
10
11
12
13
14
15
16
17
18
19